[December 11, 2012]

Research and Markets: Global Genitourinary Disorders Drug Pipeline Capsule - 2012

Research and Markets (http://www.researchandmarkets.com/research/gzzk42/global) has announced the addition of the "Global Genitourinary Disorders Drug Pipeline Capsule - 2012" report to their offering.

Fore Pharma's latest report 'Global Genitourinary Disorders Drug Pipeline Capsule - 2012' provides up-to-date information on key research and development activities in the global genitourinary drug market. It covers active pipeline molecules under development in various stages of clinical trials, preclinical research, and drug discovery for Benin Prostatic Hyperplasia, Erectile Dysfunction, Infertility, Overactive Bladder, Urinary Incontinence, and Urinary Tract Infections.

This report helps executives track their competitor's pipeline molecules. The information presented in this report can be used for identifying partners, evaluating business opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company, mechanism of action, stage (phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and drug discovery), and geography (North America, Europe, and Asia).

Key Features of the Report:

- Genitourinary Disorders Drug Pipeline Insights

- Benign Prostatic Hyperplasia Drug Pipeline Insights

- Erectile Dysfunction Drug Pipeline Insights

- Infertility Drug Pipeline Insights

- Overactive Bladder Drug Pipeline Insights

- Urinary Incontinence Drug Pipeline Insights

- Urinary Tract Infections Drug Pipeline Insights

- Tables and Figures included

For more information visit http://www.researchandmarkets.com/research/gzzk42/global

[ Back To Technology News's Homepage ]